Observational studyJournal of clinical and experimental hematopathology : JCEH2024

Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan.

Motoko Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.